SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $27,000 | -22.9% | 17,368 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $35,000 | -12.5% | 17,368 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $40,000 | -50.6% | 17,368 | -0.7% | 0.00% | -50.0% |
| Q4 2021 | $81,000 | -39.1% | 17,493 | 0.0% | 0.01% | -45.5% |
| Q3 2021 | $133,000 | -28.1% | 17,493 | -8.1% | 0.01% | -8.3% |
| Q2 2021 | $185,000 | +17.8% | 19,043 | 0.0% | 0.01% | +9.1% |
| Q1 2021 | $157,000 | -30.8% | 19,043 | -42.7% | 0.01% | -42.1% |
| Q4 2020 | $227,000 | -35.7% | 33,255 | +5.0% | 0.02% | -45.7% |
| Q3 2020 | $353,000 | +77.4% | 31,685 | +0.2% | 0.04% | +29.6% |
| Q2 2020 | $199,000 | +9850.0% | 31,635 | +7378.7% | 0.03% | +2600.0% |
| Q1 2018 | $2,000 | – | 423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |